Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Sweden flag Sweden · Delayed Price · Currency is SEK
2.100
+0.100 (5.00%)
At close: Jul 24, 2025
5.00%
Market Cap165.34M
Revenue (ttm)32.82M
Net Income (ttm)-33.48M
Shares Out78.73M
EPS (ttm)-0.56
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume290,517
Average Volume77,122
Open1.850
Previous Close2.000
Day's Range1.850 - 2.100
52-Week Range0.720 - 2.750
Beta1.07
RSI64.01
Earnings DateAug 1, 2025

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), a biotechnology company, engages in the research, development, manufacture, and supply of agarose-based separation products to purify proteins, enzymes, antibodies, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; hydrophobic interaction chromatography resins; GoBio Mini columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; desalting columns; RoboColumns and Optimo PRO 96 well screens; screening kits; and size exclusion chromatography r... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 30
Stock Exchange Nordic Growth Market
Ticker Symbol BIOWKS
Full Company Profile

Financial Performance

In 2024, Bio-Works Technologies AB's revenue was 30.49 million, a decrease of -30.55% compared to the previous year's 43.90 million. Losses were -37.36 million, -34.25% less than in 2023.

Financial Statements

News

There is no news available yet.